Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dalton MedChem Receives NIDA Research Grant | Contract Pharma

What are you searching for?

Sign in
Breaking News

Dalton MedChem Receives NIDA Research Grant

Aims to identify candidates to treat drug abuse and pain

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dalton Medicinal Chemistry has received a grant from the National Institute On Drug Abuse (NIDA) to research and discover a series of compounds with the potential to treat drug abuse and pain. Dalton will design, synthesize and test several novel classes of compounds with the goal of identifying candidates for further development.
 
Judd Berman, co-founder of Dalton Medicinal Chemistry, said, “It is exceptionally exciting to receive notice of this competitive award from National Institute On Drug Abuse (NIDA) which germinated from the creative insights of the talented scientists at Dalton. We are delighted to have the opportunity to initiate and conduct this important research.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics